×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Christopher Yea

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERAug 17, 2025Option/RSU Exercise-4,203-132,142Aug 19, 2025, 04:27 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERAug 18, 2025Sale$13.192,64934,932129,493Aug 19, 2025, 04:27 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERJul 09, 2025Sale$15.6930,250474,698127,939Jul 10, 2025, 08:50 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERMay 22, 2025Option/RSU Exercise-3,125-100,115May 27, 2025, 04:05 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERMay 23, 2025Sale$11.311,92621,78298,189May 27, 2025, 04:05 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERMay 21, 2025Option/RSU Exercise-3,750-99,307May 23, 2025, 04:25 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERMay 22, 2025Sale$11.882,31727,51696,990May 23, 2025, 04:25 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERMay 17, 2025Option/RSU Exercise-4,205-98,157May 20, 2025, 07:28 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERMay 19, 2025Sale$11.842,60030,79195,557May 20, 2025, 07:28 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERFeb 22, 2025Option/RSU Exercise-3,125-95,870Feb 25, 2025, 08:36 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERFeb 24, 2025Sale$10.021,91819,21893,952Feb 25, 2025, 08:36 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERFeb 17, 2025Option/RSU Exercise-4,204-95,346Feb 19, 2025, 08:47 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERFeb 18, 2025Sale$9.822,60125,55392,745Feb 19, 2025, 08:47 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERNov 22, 2024Option/RSU Exercise-3,125-93,105Nov 27, 2024, 08:43 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERNov 26, 2024Sale$9.871,96319,37891,142Nov 27, 2024, 08:43 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERNov 17, 2024Option/RSU Exercise-11,496-97,172Nov 19, 2024, 07:18 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERNov 18, 2024Sale$9.267,19266,57389,980Nov 19, 2024, 07:18 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERAug 22, 2024Option/RSU Exercise-3,125-87,592Aug 26, 2024, 07:58 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERAug 23, 2024Sale$12.401,91623,75885,676Aug 26, 2024, 07:58 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERAug 17, 2024Option/RSU Exercise-11,495-91,569Aug 21, 2024, 09:25 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERAug 19, 2024Sale$12.017,10285,31884,467Aug 21, 2024, 09:25 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERMay 17, 2024Option/RSU Exercise-18,789-91,684May 21, 2024, 05:55 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERMay 20, 2024Sale$11.7611,610136,58680,074May 21, 2024, 05:55 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERFeb 17, 2024Option/RSU Exercise-18,788-84,948Feb 21, 2024, 09:48 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERFeb 20, 2024Sale$14.1112,053170,12472,895Feb 21, 2024, 09:48 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaCHIEF DEVELOPMENT OFFICERFeb 14, 2024Sale$15.0139,886598,66166,160Feb 16, 2024, 04:18 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerNov 17, 2023Option/RSU Exercise-11,497-53,159Nov 21, 2023, 04:32 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerNov 20, 2023Sale$8.237,11358,53546,046Nov 21, 2023, 04:32 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerAug 17, 2023Option/RSU Exercise-11,494-48,804Aug 21, 2023, 08:06 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerAug 18, 2023Sale$10.737,14276,62441,662Aug 21, 2023, 08:06 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerMay 17, 2023Option/RSU Exercise-4,205-39,914May 19, 2023, 09:20 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerMay 18, 2023Sale$10.142,60426,41637,310May 19, 2023, 09:20 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerFeb 17, 2023Sale$7.662,72720,88935,709Feb 23, 2023, 05:42 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerFeb 17, 2023Option/RSU Exercise-4,204-38,436Feb 23, 2023, 05:42 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerNov 17, 2022Option/RSU Exercise-1,774-35,371Nov 21, 2022, 04:21 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerNov 18, 2022Sale$5.441,1396,19634,232Nov 21, 2022, 04:21 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerAug 17, 2022Option/RSU Exercise-1,773-34,742Aug 19, 2022, 05:16 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerAug 17, 2022Sale$14.961,14517,13033,597Aug 19, 2022, 05:16 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerNov 01, 2021Sale$18.075,00090,32832,969Nov 03, 2021, 04:56 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerAug 02, 2021Sale$20.525,000102,57837,969Aug 04, 2021, 07:55 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerFeb 23, 2021Sale$33.5915,000503,87762,169Feb 25, 2021, 08:25 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerOct 29, 2020Sale$17.485,00087,39462,969Nov 02, 2020, 08:01 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerOct 20, 2020Sale$17.497,942138,88676,315Oct 22, 2020, 05:36 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerOct 21, 2020Sale$18.256,044110,28270,513Oct 22, 2020, 05:36 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerOct 16, 2020Sale$17.0091415,53981,955Oct 20, 2020, 02:14 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerFeb 05, 2020Sale$17.101001,71082,869Feb 07, 2020, 05:18 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerDec 20, 2019Option/RSU Exercise$0.004302,6461185,615Dec 26, 2019, 05:32 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerDec 20, 2019Sale$17.022,64645,02582,969Dec 26, 2019, 05:32 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerDec 16, 2019Sale$17.053,01051,31882,969Dec 16, 2019, 07:34 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerDec 12, 2019Option/RSU Exercise$0.00430199183,168Dec 16, 2019, 07:34 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerDec 12, 2019Sale$17.001993,38382,969Dec 16, 2019, 07:34 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerDec 13, 2019Option/RSU Exercise$0.004301,500684,469Dec 16, 2019, 07:34 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerDec 13, 2019Sale$17.051,50025,56882,969Dec 16, 2019, 07:34 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerDec 16, 2019Option/RSU Exercise$0.004303,0101385,979Dec 16, 2019, 07:34 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerJul 22, 2019Sale$18.357,355134,93082,969Jul 24, 2019, 05:53 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerJul 22, 2019Option/RSU Exercise$0.004307,3553290,324Jul 24, 2019, 05:53 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerApr 22, 2019Option/RSU Exercise$0.004307,3553290,324Apr 23, 2019, 05:33 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerApr 22, 2019Sale$26.047,355191,53083,969Apr 23, 2019, 05:33 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerJan 25, 2019Option/RSU Exercise$0.004305,4532388,422Jan 29, 2019, 06:53 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerJan 25, 2019Sale$17.065,45393,01582,969Jan 29, 2019, 06:53 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerJan 22, 2019Option/RSU Exercise$0.004301,302684,271Jan 24, 2019, 07:48 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerJan 22, 2019Sale$17.001,30222,13982,969Jan 24, 2019, 07:48 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerJan 23, 2019Option/RSU Exercise$0.00430600383,569Jan 24, 2019, 07:48 PM
KALVKalVista Pharmaceuticals, Inc.Christopher YeaChief Development OfficerJan 23, 2019Sale$17.0160010,20582,969Jan 24, 2019, 07:48 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe